MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
LTRN — Lantern Pharma Inc. Common Stock
NasdaqLantern Pharma Inc. Common Stock
$0.95
+0.01(+1.45%)
- O
- 0.96
- H
- 1.07
- L
- 0.92
- V
- 388.63K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About LTRN
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 11, 2020
Employees16
Stock ExchangeNasdaq
Ticker SymbolLTRN
Key Financial Statistics
| Market Cap | $12.85M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.84 - $4.70 |
| 52-Week Avg Volume | 261.1K |
| VWAP | $0.98 |
| Transactions | 1,735 |
| Total Recorded Bars | 1,588 days |